<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02393339</url>
  </required_header>
  <id_info>
    <org_study_id>0638-14-HMO-CTIL</org_study_id>
    <nct_id>NCT02393339</nct_id>
  </id_info>
  <brief_title>Pre-operative Analgesics for Postoperative Pain Relief After Dental Treatment</brief_title>
  <official_title>Pre-operative Analgesics for Postoperative Pain Relief After Dental Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare the efficacy of the pre-operative administration of&#xD;
      Paracetamol and placebo in reducing postoperative pain after routine dental treatment in&#xD;
      children. This study will be a prospective, placebo-controlled, randomized, double-blind&#xD;
      trial. Patients in need of dental treatment with local anesthesia will take part in the&#xD;
      study.&#xD;
&#xD;
      Study group will receive syrup paracetamol 15 min before the dental treatment. Control group&#xD;
      will receive placebo syrup, similar in color and viscosity, 15 min before dental treatment.&#xD;
      the patient, the treating dentist, and the interviewer will be blind to the medication.&#xD;
&#xD;
      Main outcome measure: one of the main investigators will interview the patient at three time&#xD;
      points: immediately at the end of the treatment, one hour after taking the pre-operative&#xD;
      analgesic and by phone 2.5 hours after taking the pre-operative analgesic. The patient and&#xD;
      his parents will be asked if the child is crying (yes/no), complaining about pain (yes/no),&#xD;
      needed a different kind of analgesics after the treatment (yes/no). In addition, each child&#xD;
      will describe his ⁄ her feelings regarding postoperative pain, using the Wong-Baker Facial&#xD;
      Rating Pain Scale&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be a prospective, placebo-controlled, randomized, double-blind trial.&#xD;
      Patients 5-12 years old, healthy, in need of dental treatment with local anesthesia of&#xD;
      Lidocaine 2% with adrenalin 1:100,000 in the Hadassah School of Dental Medicine will take&#xD;
      part in the study. The dental treatment will include one of the following procedures:&#xD;
      restoration, pulpotomy, pulpectomy, stainless steel crown, extraction. Exclusion criteria:&#xD;
      preoperative pain, patients taking analgesics within 5 h prior to the dental treatment,&#xD;
      allergic reaction or adverse effect to paracetamol, not available (by phone) at least 2 hours&#xD;
      after treatment, patient refuse to drink the syrup.&#xD;
&#xD;
      Study group will receive syrup paracetamol 15 min before the dental treatment. Control group&#xD;
      will receive placebo syrup, similar in color and viscosity, 15 min before dental treatment.&#xD;
      the patient, the treating dentist, and the interviewer will be blind to the medication.&#xD;
&#xD;
      Data collection: age, gender, type of treatment, type of LA (infiltration /block), time of&#xD;
      taking the preoperative analgesic, type of preoperative analgesics ( 1 or 2), time at the end&#xD;
      of the treatment and baseline apprehension. Baseline anxiety will be recorded prior to the&#xD;
      procedure using Facial Image Scale.&#xD;
&#xD;
      Main outcome measure: one of the main investigators will interview the patient at three time&#xD;
      points: immediately at the end of the treatment, one hour after taking the pre-operative&#xD;
      analgesic and by phone 2.5 hours after taking the pre-operative analgesic. The patient and&#xD;
      his parents will be asked if the child is crying (yes/no), complaining about pain (yes/no),&#xD;
      needed a different kind of analgesics after the treatment (yes/no). In addition, each child&#xD;
      will describe his ⁄ her feelings regarding postoperative pain, using the Wong-Baker Facial&#xD;
      Rating Pain Scale The first two parts of the questionnaire (time 0, 1 h) will be answered in&#xD;
      the clinic and the last part (time 2.5 h) by phone; the children will have the scale with the&#xD;
      faces with them.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative Pain, as Measured by Wong-Baker Facial Rating Pain Scale ,After Routine Dental Treatment</measure>
    <time_frame>2.5 hours after taking the pre-operative analgesic.</time_frame>
    <description>This scale measures the unpleasantness or effective dimension of a child's pain experience. The child is shown a set of six cartoon faces with varying facial expressions from smile\laughter to tears. Each face has a numerical value, from 0 (smiling face) to 5 (tears). The child selects the facial expression that best represents his \her experience of discomfort.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">114</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Study group will receive syrup paracetamol (15 mg/kg) 15 min before the dental treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controll group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Control group will receive placebo syrup, designed to mimic paracetamol syrup, similar in color and viscosity, 15 min before dental treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paracetamol</intervention_name>
    <description>Pre-operative administration of Paracetamol syrup</description>
    <arm_group_label>study group</arm_group_label>
    <other_name>acetaminophen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Pre-operative administration of placebo syrup</description>
    <arm_group_label>controll group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  healthy&#xD;
&#xD;
          -  in need of dental treatment with local anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  preoperative pain,&#xD;
&#xD;
          -  patients taking analgesics within 5 h prior to the dental treatment&#xD;
&#xD;
          -  allergic reaction or adverse effect to paracetamol&#xD;
&#xD;
          -  not available (by phone) at least 2 hours after treatment&#xD;
&#xD;
          -  patient refuse to drink the syrup&#xD;
&#xD;
          -  dental treatment without local anesthesia&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hadassah Medical Organization</name>
      <address>
        <city>Jerusalem</city>
        <zip>91120</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 9, 2015</study_first_submitted>
  <study_first_submitted_qc>March 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2015</study_first_posted>
  <results_first_submitted>February 9, 2021</results_first_submitted>
  <results_first_submitted_qc>March 2, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 3, 2021</results_first_posted>
  <last_update_submitted>March 2, 2021</last_update_submitted>
  <last_update_submitted_qc>March 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hadassah Medical Organization</investigator_affiliation>
    <investigator_full_name>Avia Fux</investigator_full_name>
    <investigator_title>pediatric dentist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 29, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/39/NCT02393339/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Study Group</title>
          <description>Study group will receive syrup paracetamol (15 mg/kg) 15 min before the dental treatment&#xD;
paracetamol: Pre-operative administration of Paracetamol syrup</description>
        </group>
        <group group_id="P2">
          <title>Controll Group</title>
          <description>Control group will receive placebo syrup, designed to mimic paracetamol syrup, similar in color and viscosity, 15 min before dental treatment.&#xD;
placebo: Pre-operative administration of placebo syrup</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="56"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="51"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Study Group</title>
          <description>Study group will receive syrup paracetamol (15 mg/kg) 15 min before the dental treatment&#xD;
paracetamol: Pre-operative administration of Paracetamol syrup</description>
        </group>
        <group group_id="B2">
          <title>Controll Group</title>
          <description>Control group will receive placebo syrup, designed to mimic paracetamol syrup, similar in color and viscosity, 15 min before dental treatment.&#xD;
placebo: Pre-operative administration of placebo syrup</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="51"/>
            <count group_id="B2" value="51"/>
            <count group_id="B3" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="51"/>
                    <count group_id="B2" value="51"/>
                    <count group_id="B3" value="102"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.98" spread="1.53"/>
                    <measurement group_id="B2" value="7.08" spread="1.89"/>
                    <measurement group_id="B3" value="7" spread="1.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="51"/>
                    <count group_id="B2" value="51"/>
                    <count group_id="B3" value="102"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Israel</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="51"/>
                    <count group_id="B2" value="51"/>
                    <count group_id="B3" value="102"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="51"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Postoperative Pain, as Measured by Wong-Baker Facial Rating Pain Scale ,After Routine Dental Treatment</title>
        <description>This scale measures the unpleasantness or effective dimension of a child's pain experience. The child is shown a set of six cartoon faces with varying facial expressions from smile\laughter to tears. Each face has a numerical value, from 0 (smiling face) to 5 (tears). The child selects the facial expression that best represents his \her experience of discomfort.</description>
        <time_frame>2.5 hours after taking the pre-operative analgesic.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Study Group</title>
            <description>Study group will receive syrup paracetamol (15 mg/kg) 15 min before the dental treatment&#xD;
paracetamol: Pre-operative administration of Paracetamol syrup</description>
          </group>
          <group group_id="O2">
            <title>Controll Group</title>
            <description>Control group will receive placebo syrup, designed to mimic paracetamol syrup, similar in color and viscosity, 15 min before dental treatment.&#xD;
placebo: Pre-operative administration of placebo syrup</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain, as Measured by Wong-Baker Facial Rating Pain Scale ,After Routine Dental Treatment</title>
          <description>This scale measures the unpleasantness or effective dimension of a child's pain experience. The child is shown a set of six cartoon faces with varying facial expressions from smile\laughter to tears. Each face has a numerical value, from 0 (smiling face) to 5 (tears). The child selects the facial expression that best represents his \her experience of discomfort.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="51"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Wang-Baker Scale 0</title>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Wang-Baker Scale 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Wang-Baker Scale 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Wang-Baker Scale 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Wang-Baker Scale 4</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Wang-Baker Scale 5</title>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3.5 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Study Group</title>
          <description>Study group will receive syrup paracetamol (15 mg/kg) 15 min before the dental treatment&#xD;
paracetamol: Pre-operative administration of Paracetamol syrup</description>
        </group>
        <group group_id="E2">
          <title>Controll Group</title>
          <description>Control group will receive placebo syrup, designed to mimic paracetamol syrup, similar in color and viscosity, 15 min before dental treatment.&#xD;
placebo: Pre-operative administration of placebo syrup</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="51"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="51"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Avia Fux-Noy</name_or_title>
      <organization>Hadassah School of Dental Medicine, P.O.Box 12272</organization>
      <phone>+972507410935</phone>
      <email>fuxavia@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

